{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:46:46Z","timestamp":1790664406178,"version":"4.1.0"},"reference-count":71,"publisher":"Informa UK Limited","issue":"8","license":[{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2018,8,3]]},"DOI":"10.1080\/10428194.2017.1387905","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T13:19:32Z","timestamp":1508764772000},"page":"1785-1796","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":104,"title":["Axicabtagene ciloleucel, a first-in-class CAR T cell therapy for aggressive NHL"],"prefix":"10.1080","volume":"59","author":[{"given":"Zachary J.","family":"Roberts","sequence":"first","affiliation":[{"name":"Kite Pharma, Santa Monica, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Better","sequence":"additional","affiliation":[{"name":"Kite Pharma, Santa Monica, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Bot","sequence":"additional","affiliation":[{"name":"Kite Pharma, Santa Monica, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margo R.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Kite Pharma, Santa Monica, CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Ribas","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California at Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,10,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83871"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.25"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.36"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2015.01.002"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000000232"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/asheducation.V2012.1.143.3798224","volume":"2012","author":"Brentjens RJ","year":"2012","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348540"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0666"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181ac6138"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-265041"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-281931"},{"key":"CIT0012","volume-title":"SEER cancer statistics review, 1975\u20132013","author":"Howlader NNA"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14136"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2011.02.006"},{"key":"CIT0015","first-page":"428","volume":"19","author":"Petkovic I.","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-06-649905"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-491514"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177204"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-575092"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621375"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.1618"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.498"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2011.40"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-12-128843"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.15"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3322"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-3017"},{"key":"CIT0029","first-page":"2308","volume-title":"Proceedings of the 105th Annual Meeting American Association Cancer Research;","author":"Better M","year":"2015"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-0016(16)33096-9"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.12.003"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.71.3024"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.5449"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1126\/science.1076514"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2025"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf8621"},{"key":"CIT0037","first-page":"S791","volume":"21","author":"Siddiqi T","year":"2016","journal-title":"Mol Ther"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-10-384388"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.07.004"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2016.10.020"},{"key":"CIT0041","doi-asserted-by":"crossref","unstructured":"Locke FL, Neelapu SS, Bartlett NL, et\u00a0al. Primary results from ZUMA-1: a pivotal trial of axicabtagene ciloleucel (Axi-cel; KTE-C19) in patients with refractory aggressive non-Hodgkin lymphoma (NHL). Proceedings of the 107th Annual Meeting American Association Cancer Research; Washington (DC): AACR; 2017. p. CT019.","DOI":"10.1158\/1538-7445.AM2017-CT019"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw375.40"},{"key":"CIT0043","doi-asserted-by":"crossref","first-page":"TPS7075","DOI":"10.1200\/JCO.2016.34.15_suppl.TPS7075","volume":"34","author":"Wayne A","year":"2016","journal-title":"J Clin Oncol"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw368.58"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61403-3"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac5415"},{"key":"CIT0048","first-page":"4426","volume":"126","author":"Bot A","year":"2015","journal-title":"ASH Ann Meeting Abstracts"},{"key":"CIT0049","doi-asserted-by":"crossref","unstructured":"Neelapu S, Locke F, Bartlett N, et\u00a0al. Ongoing complete remissions (CR) in the phase 1 of ZUMA-1: a phase 1-2 multicenter study evaluating the safety and efficacy of KTE-C19 (anti-CD19 CAR T cells) in subjects with refractory aggressive B-cell non-Hodgkin lymphoma (NHL). Vol. 34. ASCO Annual Meeting; 2016; Chicago, IL.","DOI":"10.1093\/annonc\/mdw378.02"},{"key":"CIT0050","unstructured":"Rossi J, Sherman M, Xue A, et\u00a0al. Low dose conditioning chemotherapy and CD19-directed CAR T cells May elicit distinct immune programs associated with clinical responses. SITC Meeting Abstracts; 2016; Los Angeles, CA."},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.11"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-552729"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1177\/2040620716640422"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv439"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000035"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-12-580068"},{"key":"CIT0057","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1182\/blood.V128.22.586.586","author":"Gardner R","year":"2016","journal-title":"Blood"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2015.5"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-635334"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002842"},{"key":"CIT0061","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.4049\/jimmunol.151.11.6577","volume":"151","author":"Stancovski I","year":"1993","journal-title":"J Immunol"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12131"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201601902"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.61"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1524155113"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0108"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-15-0231"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-495531"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83092"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.4161\/onci.26286"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679134"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2017.1387905","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2017.1387905","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T11:50:01Z","timestamp":1693137001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2017.1387905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,23]]},"references-count":71,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,1,3]]},"published-print":{"date-parts":[[2018,8,3]]}},"alternative-id":["10.1080\/10428194.2017.1387905"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2017.1387905","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"}]}}